Genmab | GEN - Trade Creditors

Stock Price
2,058.00
Daily Change
-39.00 -1.86%
Monthly
2.39%
Yearly
46.74%
Q1 Forecast
1,920.90

Genmab reported DKK6M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agios Pharmaceuticals USD 19.55M 2.02M Sep/2025
Almirall EUR 199.39M 50.03M Jun/2025
Amarin USD 36.71M 8M Sep/2025
Amgen USD 19.64B 1.61B Sep/2025
argenx SE USD 852.2M 369.5M Jun/2025
AstraZeneca USD 25.03B 1.04B Sep/2025
Bayer EUR 6.38B 343M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Demant DKK 923M 41M Dec/2025
Exelixis USD 25.35M 471K Sep/2025
Fresenius Medical Care EUR 725.85M 25.9M Sep/2025
Galapagos EUR 100.63M 32.55M Sep/2025
Genmab DKK 6M 2M Sep/2025
GlaxoSmithKline GBP 15.68B 855M Sep/2025
GN Store Nord DKK 1.4B 70M Sep/2025
GRIFOLS EUR 878.68M 26.38M Jun/2025
Hikma Pharmaceutical USD 611M 253M Jun/2025
Insmed USD 79.59M 1.24M Sep/2025
Lonza CHF 471M 3M Dec/2024
Merck EUR 1.93B 32M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
UCB EUR 3.29B 2.54B Jun/2025